Medinotec (MDNC) Net Income towards Common Stockholders Growth (1y) (2023 - 2026)
Powered by 
Analysis
Medinotec (MDNC) Net Income towards Common Stockholders Growth (1y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.92% |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | -60.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -60.33% |
| Feb 28, 2026 | -114.55% |
| Nov 30, 2025 | 59.16% |
| Aug 31, 2025 | 16.49% |
| May 31, 2025 | 502.75% |
| Feb 28, 2025 | 700.84% |
| Nov 30, 2024 | 167.53% |
| Aug 31, 2024 | 768.46% |
| May 31, 2024 | 375.23% |
| Feb 29, 2024 | 660.03% |
| Nov 30, 2023 | -2,342.02% |
| Aug 31, 2023 | 79.92% |
| May 31, 2023 | 121.87% |
| Feb 28, 2023 | 42.34% |